INS and metabolic syndrome: An ongoing phase I clinical study (NCT02469272) examining small intestinal microbiota transfers from lean to obese subjects has shown improved insulin sensitivity in patients with metabolic syndrome as well as improved insulin sensitivity in those with NASH [37,72,73].